Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1999 1
2000 1
2002 3
2004 1
2007 1
2010 2
2011 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Systemic treatment of colorectal cancer.
Tebbutt NC, Cattell E, Midgley R, Cunningham D, Kerr D. Tebbutt NC, et al. Among authors: cattell e. Eur J Cancer. 2002 May;38(7):1000-15. doi: 10.1016/s0959-8049(02)00062-x. Eur J Cancer. 2002. PMID: 11978525 Review.
Quinone oxidoreductase-2-mediated prodrug cancer therapy.
Middleton MR, Knox R, Cattell E, Oppermann U, Midgley R, Ali R, Auton T, Agarwal R, Anderson D, Sarker D, Judson I, Osawa T, Spanswick VJ, Davies S, Hartley JA, Kerr DJ. Middleton MR, et al. Among authors: cattell e. Sci Transl Med. 2010 Jul 14;2(40):40ra50. doi: 10.1126/scitranslmed.3000615. Sci Transl Med. 2010. PMID: 20630857 Free article. Clinical Trial.
Assessing outcomes in palliative chemotherapy.
Cattell E, Arance A, Middleton M. Cattell E, et al. Expert Opin Pharmacother. 2002 Jun;3(6):693-700. doi: 10.1517/14656566.3.6.693. Expert Opin Pharmacother. 2002. PMID: 12036408 Review.
Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
Wang AT, Sengerová B, Cattell E, Inagawa T, Hartley JM, Kiakos K, Burgess-Brown NA, Swift LP, Enzlin JH, Schofield CJ, Gileadi O, Hartley JA, McHugh PJ. Wang AT, et al. Among authors: cattell e. Genes Dev. 2011 Sep 1;25(17):1859-70. doi: 10.1101/gad.15699211. Genes Dev. 2011. PMID: 21896658 Free PMC article.
Antiangiogenic therapy for von Hippel-Lindau disease.
Madhusudan S, Deplanque G, Braybrooke JP, Cattell E, Taylor M, Price P, Tsaloumas MD, Moore N, Huson SM, Adams C, Frith P, Scigalla P, Harris AL. Madhusudan S, et al. Among authors: cattell e. JAMA. 2004 Feb 25;291(8):943-4. doi: 10.1001/jama.291.8.943. JAMA. 2004. PMID: 14982909 Clinical Trial. No abstract available.
A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancer.
Talbot DC, von Pawel J, Cattell E, Yule SM, Johnston C, Zandvliet AS, Huitema AD, Norbury CJ, Ellis P, Bosquee L, Reck M. Talbot DC, et al. Among authors: cattell e. Clin Cancer Res. 2007 Mar 15;13(6):1816-22. doi: 10.1158/1078-0432.CCR-06-0249. Clin Cancer Res. 2007. PMID: 17363538 Free article. Clinical Trial.
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page